Most Recent
AFT Pharmaceuticals has agreed to a court order temporarily restraining it from distributing point of sale material containing updated claims that its painkiller Maxigesic is more effective than other over-the-counter medications.
German pharmaceutical company Boehringer has struck back at a patent lawsuit brought by Teva, filing a cross-claim alleging Teva is threatening to infringe three of its patents related to its blockbuster inhaler Spiriva with the planned launch of a competing inhaler in Australia.
Auto electronics maker B8 Systems has settled a patent suit brought by rival Redarc Group and has agreed to stop selling its allegedly infringing vehicle brake controller in Australia.
A judge's decision imposing damages of over $2.8 million on a Melbourne computer retailer facing an intellectual property lawsuit by Microsoft has been slammed as "regrettable" and a judicial "failure," in a judgment overturning the ruling.
A serviced apartments provider has discontinued its appeal of a ruling that blocked it from trade marking the phrase "Waldorf Apartment", after Hilton Worldwide — which owns New York’s iconic Waldorf Astoria hotel - opposed the move.
Danish pharmaceutical giant Lundbeck secured $51.7 million in settlements to end infringement litigation with three generic makers over its patent for the top-selling Lexapro, the company has revealed.
Otsuka Pharmaceuticals and Bristol Myers-Squibb can retain their defences in an ongoing patent dispute over antipsychotic drug Abilify, after the Federal Court dismissed a strike out bid by the Commonwealth of Australia over the allegedly "inconsistent" pleadings.
Hytera has challenged Motorola's claims that it owns the copyright for the digital radio source code that's at the centre of copyright allegations against the Chinese radio maker.
A damages battle in an infringement case over two patents for the ubiquitous plastic produce containers found in grocery stores across Australia is over, with the fight settling ahead of a hearing.
Railway technology company Wavetrain Systems has dropped its bid for a court order barring a competitor started by its former CEO from making allegedly false claims about its patented rail safety devices to clients.